Fast Delivery 
Global Compliance 
Long Term Support
What is the MDD to MDR transition? The MDD to MDR transition is one of the most important regulatory changes currently affecting medical device manufacturers in Europe. Although the Medical Device Directive (MDD) has been replaced by the Medical Device Regulation (MDR), many companies are still moving legacy products through the transition under extended EU […]
A domestic refrigerator is designed for food, not for temperature-sensitive vaccines and medicines. When you’re storing products that must remain effective and safe, the “best medical fridge” is the one that can maintain a stable target temperature, recover quickly after door openings, and support monitoring and documentation for your cold chain processes. This guide explains […]
ARCTIKO has officially relocated to a new shared headquarters in Salisbury alongside Lascar Electronics, reinforcing its commitment to innovation, operational excellence and enhanced service. The move unites teams that were previously based across multiple Salisbury locations into one central facility, strengthening collaboration and operational efficiency. Advancing Cold Storage & Monitoring Integration ARCTIKO specialises in high-performance […]
This technical whitepaper examines the cascade refrigeration system commonly used in ultra-low temperature (ULT) freezers and compares it with ARCTIKO’s TRUE DUAL™ cooling architecture, focusing on reliability, temperature uniformity, uptime and total cost of ownership in critical −80°C storage environments. Cascade Refrigeration Systems and Alternative ULT Architectures Ultra-low temperature (ULT) refrigeration is essential in life […]
Medical refrigeration is essential for storing potentially life-saving medications, vaccinations and blood products. Medical refrigerator temperature monitoring plays a critical role in maintaining safe fridge temperature conditions and supporting modern healthcare operations. Temperature variation is a major concern in medical refrigeration. Even small deviations can compromise product integrity, which is why continuous temperature monitoring is […]
Who Is This Guide For? This guide is intended for blood bank and transfusion service managers, hospital and laboratory professionals, healthcare procurement teams and facilities responsible for cold chain management. It is relevant across hospital blood banks, regional transfusion centres and specialist healthcare environments. A Guide to Blood Bank Storage Blood Bank Storage is a […]
Ultra-low temperature freezers are essential across scientific, medical and industrial sectors, providing ultra cold storage for highly sensitive materials. Designed to operate at ultra low temperature ranges, these systems help protect sample integrity, ensure stability and reduce long-term risk. This guide explores the cost, energy efficiency, lifespan, temperature requirements and applications of an ULT freezer, […]
We are moving to a new office! While this won’t change how we operate day to day, we want to reassure our customers about what to expect during this transition and highlight the benefits that come with a fresh new space. The simple truth is that very little will change, which is exactly how it should be. Your usual contacts remain the same, and all […]
Protecting valuable biological materials requires reliable, ultra-low temperatures. While –80 °C freezers remain widely used for general biobanking and molecular biology samples, certain applications, including regenerative medicine, reproductive cells and advanced therapies, demand colder, more stable storage. Traditionally, cryogenic storage has meant liquid nitrogen (LN₂) tanks. Today, cryogenic freezers achieve –150°C using advanced mechanical refrigeration […]
What is GLP-1? GLP-1 (Glucagon-like Peptide-1) is a hormone that regulates blood sugar and appetite. GLP-1 drugs (e.g., Ozempic, Wegovy, Trulicity) mimic this hormone to treat type 2 diabetes and obesity. As one of the fastest-growing pharmaceutical markets, GLP-1 therapies are forecasted to exceed $100 billion by 2030. For more information on GLP-1 therapies, see […]